S.C. Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$246K Buy
+3,634
New +$213K 0.38% 89
2022
Q3
Sell
-3,634
Closed -$202K 123
2022
Q2
$202K Buy
3,634
+20
+0.6% +$1.11K 0.31% 112
2022
Q1
$201K Buy
+3,614
New +$185K 0.26% 117

Other funds holding NVO

S.C. Financial Services's NVO Position: Q4 2022 in Review

S.C. Financial Services opened a new position in Novo Nordisk (NVO) in Q4 2022: 3,634 shares worth $246K. The stake represents 0.38% of the portfolio and ranks #89 among its holdings. This is a return to the name: S.C. Financial Services previously reported a position in NVO as recently as Q2 2022.

S.C. Financial Services first reported a position in NVO in Q1 2022 and has held it in 3 quarters since. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • S.C. Financial Services held 3,634 shares of Novo Nordisk worth $246K as of Q4 2022.
  • Novo Nordisk was a new S.C. Financial Services position in Q4 2022.
  • Novo Nordisk made up 0.38% of S.C. Financial Services's portfolio in Q4 2022, its #89 holding.
  • S.C. Financial Services first reported a position in Novo Nordisk in Q1 2022 and has held it in 3 quarters since.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on S.C. Financial Services's 13F filing for Q4 2022, filed 20 Jan 2023.